Friedreich's Ataxia Completed Phase 2 Trials for Leriglitazone (DB15021)
Also known as: Friedreich Ataxia / Friedreich's ataxia (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0037758 (Friedreich's Ataxia) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03917225 | A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients | Treatment |